These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Aliskiren: a new inhibitor of renin-angiotensin aldosterone system activity. Dalla Vestra M, Simioni N, Masiero A. Minerva Endocrinol; 2009 Dec; 34(4):333-8. PubMed ID: 20046162 [Abstract] [Full Text] [Related]
11. Aliskiren in the management of hypertension. Barrios V, Escobar C. Am J Cardiovasc Drugs; 2010 Dec; 10(6):349-58. PubMed ID: 21090828 [Abstract] [Full Text] [Related]
12. Clinical role of direct renin inhibition in hypertension. Taylor AA, Pool JL. Am J Ther; 2012 May; 19(3):204-10. PubMed ID: 21317620 [Abstract] [Full Text] [Related]
14. Aliskiren in the treatment of hypertension and organ damage. Riccioni G. Cardiovasc Ther; 2011 Feb; 29(1):77-87. PubMed ID: 21106033 [Abstract] [Full Text] [Related]
15. Direct inhibition of renin: a physiological approach to treat hypertension and cardiovascular disease. Ram CV. Future Cardiol; 2009 Sep; 5(5):453-65. PubMed ID: 19715410 [Abstract] [Full Text] [Related]
16. Renin inhibitors: novel agents for renoprotection or a better angiotensin receptor blocker for blood pressure lowering? Pimenta E, Oparil S. Cardiol Clin; 2008 Nov; 26(4):527-35. PubMed ID: 18929229 [Abstract] [Full Text] [Related]
20. The efficacy of aliskiren, a direct renin inhibitor, in the treatment of hypertension. Gradman AH, Traub D. Rev Cardiovasc Med; 2007 Nov; 8 Suppl 2():S22-30. PubMed ID: 17401313 [Abstract] [Full Text] [Related] Page: [Next] [New Search]